Table 3.
Location | Year | Identified lesion | Status | |
---|---|---|---|---|
B. suis biovar 4 | Serology | |||
Ulukhaktok | 1996 | Lymphadenitis | Negative | Negative1 |
Ulukhaktok | 1996 | Nephritis, splenitis, lymphadenitis | Positive | n/a |
Ulukhaktok | 1996 | Lymphadenitis | Negative | Negative1 |
Cambridge Bay | 1998 | Skin abscess | Negative | Negative1 |
Cambridge Bay | 1998 | Squamous cell carcinoma | Negative | Negative1 |
Cambridge Bay | 1998 | Lymphadenitis | Negative | Negative1 |
Cambridge Bay | 1998 | Lymphadenitis | Positive | Negative1 |
Cambridge Bay | 1998 | Fat abscess | Negative | Negative1 |
Cambridge Bay | 1998 | Lymphadenitis | Negative | Negative1 |
Cambridge Bay | 1998 | Lymphadenitis | Negative | Negative1 |
Cambridge Bay | 1998 | Lymphadenitis | Negative | Negative1 |
Cambridge Bay | 2014 | Metatarsal abscess | Positivea | Positive2 |
Cambridge Bay | 2016 | Bilateral abscesses in the vagina | Negative | Negative2 |
Cambridge Bay | 2016 | Granulomatous mastitis, endometritis, lymphadenitis, nephritis | Positive | Positive2 |
Bacteriology status of muskoxen was determined by culturing tissues with identified lesions; while serology status of muskoxen was determined by BPAT on sera (1), A/G iELISA on paired sera and filter papers eluates (2), or was not available (n/a).
aTomaselli et al. (2016).